Abstract
HIV-1 genotypic susceptibility scores (GSSs) were proven to be significant prognostic factors of fixed time-point virologic outcomes after combination antiretroviral therapy (cART) switch/initiation. However, their relative-hazard for the time to virologic failure has not been thoroughly investigated, and an expert system that is able to predict how long a new cART regimen will remain effective has never been designed.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 40-40 |
| Numero di pagine | 1 |
| Rivista | BMC Medical Informatics and Decision Making |
| Volume | 11 |
| Numero di pubblicazione | Giugno |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2011 |
Keywords
- Adult
- Anti-HIV Agents
- Cohort Studies
- Combination
- Drug Therapy
- Female
- HIV Infections
- HIV-1
- Humans
- Male
- Middle Aged
- Proportional Hazards Models
- Treatment Failure
- Viral Load